|
|
Volumn 20, Issue 4, 2010, Pages 521-522
|
|
Henoch-Schönlein purpura in a patient with rheumatoid arthritis receiving etanercept
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
C REACTIVE PROTEIN;
COMPLEMENT;
COMPLEMENT COMPONENT C3;
COMPLEMENT COMPONENT C4;
COMPLEMENT COMPONENT CH50;
DAPSONE;
ETANERCEPT;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN G;
LEFLUNOMIDE;
PREDNISOLONE;
RHEUMATOID FACTOR;
TOCILIZUMAB;
UNCLASSIFIED DRUG;
ANTIRHEUMATIC AGENT;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
ANAPHYLACTOID PURPURA;
CASE REPORT;
CORTICOSTEROID THERAPY;
DISEASE EXACERBATION;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
IMMUNOFLUORESCENCE;
LABORATORY TEST;
LETTER;
LEUKOCYTOSIS;
RHEUMATOID ARTHRITIS;
TREATMENT OUTCOME;
ARTHRITIS, RHEUMATOID;
CHEMICALLY INDUCED;
MIDDLE AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
MIDDLE AGED;
PURPURA, SCHOENLEIN-HENOCH;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
|
EID: 77954729810
PISSN: 11671122
EISSN: 19524013
Source Type: Journal
DOI: 10.1684/ejd.2010.0977 Document Type: Letter |
|
Times cited : (18)
|
|
References (6)
|
